Sfoglia per ???browse.type.metadata.subjectIsicrui??? Biologia Sperimentale
Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence
2011-01-18 Lenci, I; Tisone, G; Di Paolo, D; Marcuccilli, F; Tariciotti, L; Ciotti, M; Svicher, V; Perno, Cf; Angelico, M
Selected Amino Acid Mutations in HIV-1 B Subtype gp41 are Associated with Specific gp120v3 Signatures in the Regulation of Co-Receptor Usage
2011-05-12 Dimonte, S; Mercurio, F; Svicher, V; D'Arrigo, R; Perno, Cf; CECCHERINI SILBERSTEIN, F
'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing
2011-09-01 Alteri, C; Santoro, M; Abbate, I; Rozera, G; Bruselles, A; Bartolini, B; Gori, C; Forbici, F; Orchi, N; Tozzi, V; Palamara, G; Antinori, A; Narciso, P; Girardi, E; Svicher, V; CECCHERINI SILBERSTEIN, F; Capobianchi, M; Perno, Cf
'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing
2011-09-02 Alteri, C; Santoro, M; Abbate, I; Rozera, G; Bruselles, A; Bartolini, B; Gori, C; Forbici, F; Orchi, N; Tozzi, V; Palamara, G; Antinori, A; Narciso, P; Girardi, E; Svicher, V; CECCHERINI SILBERSTEIN, F; Capobianchi, M; Perno, Cf
Sequential transmission and long-term persistence of an HIV strain partially resistant to protease inhibitors
2009-04-01 Polilli, E; Di Masi, F; Sozio, F; Mazzotta, E; Alterio, L; Cosentino, L; Clerico, L; Perno, Cf; Parruti, G
Signature mutations in V3 and bridging sheet domain of HIV-1 gp120 are specifically associated with dual tropism and modulate the interaction with CCR5 N-terminus
2011-01-01 Alteri, C; Artese, A; Zang, J; Mercurio, F; Costa, G; Stazi, F; Fabeni, L; Bertoli, A; Forbici, F; Salpini, R; Dimonte, S; Alcaro, S; CECCHERINI SILBERSTEIN, F; Perno, Cf; Svicher, V
Specific HbsAg genetic determinants are associated with occult HBV infection in vivo and HbsAg detection
2011-01-01 Svicher, V; Cento, V; Bernassola, M; Neumann Fraune, M; Chen, M; Salpini, R; Chang, L; Longo, R; Visca, M; Romano, S; Micheli, V; Bertoli, A; Gubertini, G; Marino, N; Mazzotta, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spanò, A; CECCHERINI SILBERSTEIN, F; Zhan, J; Verheyen, J; Cappiello, G; Perno, Cf
Specific HBSAG Genetic- Determinants are associated with occult HBV-infection in vivo and HBSAG detection
2011-01-01 Svicher, V; Cento, V; Bernassola, M; Neumann Fraune, M; Salpini, R; Longo, R; Visca, M; Romano, S; Michieli, V; Bertoli, A; Gubertini, G; Marino, N; Mazzotta, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spanò, A; CECCHERINI SILBERSTEIN, F; Verheyen, J; Cappiello, G; Perno, Cf
Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors
2010-11-01 CECCHERINI SILBERSTEIN, F; Malet, I; Fabeni, L; Dimonte, S; Svicher, V; D'Arrigo, R; Artese, A; Costa, G; Bono, S; Alcaro, S; Monforte, A; Katlama, C; Calvez, V; Antinori, A; Marcelin, A; Perno, Cf
Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment
2006-10-01 Aquaro, S; D'Arrigo, R; Svicher, V; Perri, G; Caputo, S; Visco Comandini, U; Santoro, M; Bertoli, A; Mazzotta, F; Bonora, S; Tozzi, V; Bellagamba, R; Zaccarelli, M; Narciso, P; Antinori, A; Perno, Cf
Structured treatment interruption in HIV-infected patients failing on multidrug therapy: is there a future for this strategy?
2005-10-14 Antinori, A; Cingolani, A; Perno, Cf
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance
2011-06-15 Sarrecchia, C; Svicher, V; Volpi, A; Salpini, R; Ceccarelli, L; Sordillo, P; Bertoli, A; Perno, Cf; Andreoni, M
Sulpiride and the role of dopaminergic receptor blockade in the antipsychotic activity of neuroleptics
1981-04-01 Memo, M; Battaini, Fm; Spano, P; Trabucchi, Mm
TAp73 contributes to the oxidative stress response by regulating protein synthesis
2018-01-01 Marini, A; Rotblat, B; Sbarrato, T; Niklison-Chirou, Mv; Knight, Jrp; Dudek, K; Jones, C; Bushell, M; Knight, Ra; Amelio, I; Willis, Ae; Melino, G
Targeting TLR/IL-1R signalling in human diseases
2010-01-01 Loiarro, M; Ruggiero, V; Sette, C
Telomerase activity, hTERT expression, and phosphorylation are downregulated in CD4(+) T lymphocytes infected with human immunodeficiency virus type 1 (HIV-1)
2007-05-01 Franzese, O; Adamo, R; Pollicita, M; Comandini, A; Laudisi, A; Perno, Cf; Aquaro, S; Bonmassar, E
Temporal change in the use of genotypic resistance testing over the years 1999--2003
2004-04-01 Santoro, M; CECCHERINI SILBERSTEIN, F; Gori, C; Svicher, V; Forbici, F; Bellocchi, M; D'Arrigo, R; Bertoli, A; Giannella, S; Trotta, M; Bonfigli, S; Antinori, A; Perno, Cf
Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy
2006-04-01 Santoro, M; Svicher, V; Gori, C; Zaccarelli, M; Tozzi, V; Forbici, F; D'Arrigo, R; Trotta, M; Bellocchi, M; Visco Comandini, U; Cenci, A; Bertoli, A; Narciso, P; Antinori, A; Perno, Cf; CECCHERINI SILBERSTEIN, F
The amino acid Asn136 in HIV-1 reverse transcriptase (RT) maintains efficient association of both RT subunits and enables the rational design of novel RT inhibitors
2005-01-01 Balzarini, J; Auwerx, J; Rodriguez Barrios, F; Chedad, A; Farkas, V; CECCHERINI SILBERSTEIN, F; Garcia Aparicio, C; Velazquez, S; De, C; E, ; Perno, Cf; Camarasa, M; Gago, F
The challenge of antiretroviral-drug-resistant HIV: is there any possible clinical advantage?
2004-07-01 Zaccarelli, M; Tozzi, V; Perno, Cf; Antinori, A
Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
---|---|---|---|---|
18-gen-2011 | Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence | Lenci, I; Tisone, G; Di Paolo, D; Marcuccilli, F; Tariciotti, L; Ciotti, M; Svicher, V; Perno, Cf; Angelico, M | Articolo su rivista | |
12-mag-2011 | Selected Amino Acid Mutations in HIV-1 B Subtype gp41 are Associated with Specific gp120v3 Signatures in the Regulation of Co-Receptor Usage | Dimonte, S; Mercurio, F; Svicher, V; D'Arrigo, R; Perno, Cf; CECCHERINI SILBERSTEIN, F | Articolo su rivista | |
1-set-2011 | 'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing | Alteri, C; Santoro, M; Abbate, I; Rozera, G; Bruselles, A; Bartolini, B; Gori, C; Forbici, F; Orchi, N; Tozzi, V; Palamara, G; Antinori, A; Narciso, P; Girardi, E; Svicher, V; CECCHERINI SILBERSTEIN, F; Capobianchi, M; Perno, Cf | Articolo su rivista | |
2-set-2011 | 'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing | Alteri, C; Santoro, M; Abbate, I; Rozera, G; Bruselles, A; Bartolini, B; Gori, C; Forbici, F; Orchi, N; Tozzi, V; Palamara, G; Antinori, A; Narciso, P; Girardi, E; Svicher, V; CECCHERINI SILBERSTEIN, F; Capobianchi, M; Perno, Cf | Articolo su rivista | |
1-apr-2009 | Sequential transmission and long-term persistence of an HIV strain partially resistant to protease inhibitors | Polilli, E; Di Masi, F; Sozio, F; Mazzotta, E; Alterio, L; Cosentino, L; Clerico, L; Perno, Cf; Parruti, G | Articolo su rivista | |
1-gen-2011 | Signature mutations in V3 and bridging sheet domain of HIV-1 gp120 are specifically associated with dual tropism and modulate the interaction with CCR5 N-terminus | Alteri, C; Artese, A; Zang, J; Mercurio, F; Costa, G; Stazi, F; Fabeni, L; Bertoli, A; Forbici, F; Salpini, R; Dimonte, S; Alcaro, S; CECCHERINI SILBERSTEIN, F; Perno, Cf; Svicher, V | Intervento a convegno | |
1-gen-2011 | Specific HbsAg genetic determinants are associated with occult HBV infection in vivo and HbsAg detection | Svicher, V; Cento, V; Bernassola, M; Neumann Fraune, M; Chen, M; Salpini, R; Chang, L; Longo, R; Visca, M; Romano, S; Micheli, V; Bertoli, A; Gubertini, G; Marino, N; Mazzotta, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spanò, A; CECCHERINI SILBERSTEIN, F; Zhan, J; Verheyen, J; Cappiello, G; Perno, Cf | Intervento a convegno | |
1-gen-2011 | Specific HBSAG Genetic- Determinants are associated with occult HBV-infection in vivo and HBSAG detection | Svicher, V; Cento, V; Bernassola, M; Neumann Fraune, M; Salpini, R; Longo, R; Visca, M; Romano, S; Michieli, V; Bertoli, A; Gubertini, G; Marino, N; Mazzotta, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spanò, A; CECCHERINI SILBERSTEIN, F; Verheyen, J; Cappiello, G; Perno, Cf | Intervento a convegno | |
1-nov-2010 | Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors | CECCHERINI SILBERSTEIN, F; Malet, I; Fabeni, L; Dimonte, S; Svicher, V; D'Arrigo, R; Artese, A; Costa, G; Bono, S; Alcaro, S; Monforte, A; Katlama, C; Calvez, V; Antinori, A; Marcelin, A; Perno, Cf | Articolo su rivista | |
1-ott-2006 | Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment | Aquaro, S; D'Arrigo, R; Svicher, V; Perri, G; Caputo, S; Visco Comandini, U; Santoro, M; Bertoli, A; Mazzotta, F; Bonora, S; Tozzi, V; Bellagamba, R; Zaccarelli, M; Narciso, P; Antinori, A; Perno, Cf | Articolo su rivista | |
14-ott-2005 | Structured treatment interruption in HIV-infected patients failing on multidrug therapy: is there a future for this strategy? | Antinori, A; Cingolani, A; Perno, Cf | Articolo su rivista | |
15-giu-2011 | Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance | Sarrecchia, C; Svicher, V; Volpi, A; Salpini, R; Ceccarelli, L; Sordillo, P; Bertoli, A; Perno, Cf; Andreoni, M | Articolo su rivista | |
1-apr-1981 | Sulpiride and the role of dopaminergic receptor blockade in the antipsychotic activity of neuroleptics | Memo, M; Battaini, Fm; Spano, P; Trabucchi, Mm | Articolo su rivista | |
1-gen-2018 | TAp73 contributes to the oxidative stress response by regulating protein synthesis | Marini, A; Rotblat, B; Sbarrato, T; Niklison-Chirou, Mv; Knight, Jrp; Dudek, K; Jones, C; Bushell, M; Knight, Ra; Amelio, I; Willis, Ae; Melino, G | Articolo su rivista | |
1-gen-2010 | Targeting TLR/IL-1R signalling in human diseases | Loiarro, M; Ruggiero, V; Sette, C | Articolo su rivista | |
1-mag-2007 | Telomerase activity, hTERT expression, and phosphorylation are downregulated in CD4(+) T lymphocytes infected with human immunodeficiency virus type 1 (HIV-1) | Franzese, O; Adamo, R; Pollicita, M; Comandini, A; Laudisi, A; Perno, Cf; Aquaro, S; Bonmassar, E | Articolo su rivista | |
1-apr-2004 | Temporal change in the use of genotypic resistance testing over the years 1999--2003 | Santoro, M; CECCHERINI SILBERSTEIN, F; Gori, C; Svicher, V; Forbici, F; Bellocchi, M; D'Arrigo, R; Bertoli, A; Giannella, S; Trotta, M; Bonfigli, S; Antinori, A; Perno, Cf | Articolo su rivista | |
1-apr-2006 | Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy | Santoro, M; Svicher, V; Gori, C; Zaccarelli, M; Tozzi, V; Forbici, F; D'Arrigo, R; Trotta, M; Bellocchi, M; Visco Comandini, U; Cenci, A; Bertoli, A; Narciso, P; Antinori, A; Perno, Cf; CECCHERINI SILBERSTEIN, F | Articolo su rivista | |
1-gen-2005 | The amino acid Asn136 in HIV-1 reverse transcriptase (RT) maintains efficient association of both RT subunits and enables the rational design of novel RT inhibitors | Balzarini, J; Auwerx, J; Rodriguez Barrios, F; Chedad, A; Farkas, V; CECCHERINI SILBERSTEIN, F; Garcia Aparicio, C; Velazquez, S; De, C; E, ; Perno, Cf; Camarasa, M; Gago, F | Articolo su rivista | |
1-lug-2004 | The challenge of antiretroviral-drug-resistant HIV: is there any possible clinical advantage? | Zaccarelli, M; Tozzi, V; Perno, Cf; Antinori, A | Articolo su rivista |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile